Month: April 2022

Apr 25 2022

Uncategorized

Global Schizophrenia Drugs Market Research Report 2022-2027 – Injectable-Based Treatment of Schizophrenia Exhibits a Significant Growth

by Clinical Editor

No Comments

The “Global Schizophrenia Drugs Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis” report has been added to ResearchAndMarkets.com’s …

Apr 25 2022

Uncategorized

COVID and schizophrenia: Why this deadly mix can deepen knowledge of the brain disease

by Clinical Editor

No Comments

But sometimes they get loud and mean — like when a deadly pandemic descended on the world. “It’s when things go really, really fast and they seem overwhelmingly disastrous. That’s...

Apr 25 2022

Uncategorized

What is the Difference Between Schizophrenia and Schizoaffective Disorder?

by Clinical Editor

No Comments

Schizophrenia and schizoaffective disorder are two separate psychiatric conditions that remain as two distinct diagnostic systems. Schizoaffective disorder is critically distinguished from …

Apr 25 2022

Uncategorized

Scientists study COVID, schizophrenia to learn more about brain disease

by Clinical Editor

No Comments

Most of the time, the voices in Keris Myrick’s head don’t bother her. They stay in the background or say nice things. But sometimes they get loud and mean —...

Apr 24 2022

Uncategorized

Schizophrenia: The Recovery Process

by Clinical Editor

No Comments

Recovery from schizophrenia can be a slow process. However, it is important to never give up and always strive for wellness and a better life. I have been in full...

Apr 24 2022

Uncategorized

COVID and schizophrenia: Why this deadly mix can deepen knowledge of the brain disease

by Clinical Editor

No Comments

But sometimes they get loud and mean — like when a deadly pandemic descended on the world. “It’s when things go really, really fast and they seem overwhelmingly disastrous. That’s...

Apr 24 2022

Uncategorized

FDA declines to move forward with schizophrenia treatment

by Clinical Editor

No Comments

The FDA has issued a Complete Response Letter for the New Drug Application for risperidone extended-release injectable for subcutaneous use, a schizophrenia treatment, Teva Pharmaceuticals and …

Apr 24 2022

Uncategorized

Scientists study COVID, schizophrenia to learn more about brain disease

by Clinical Editor

No Comments

Most of the time, the voices in Keris Myrick’s head don’t bother her. They stay in the background or say nice things. But sometimes they get loud and mean —...

Apr 24 2022

Uncategorized

FDA delays approval for Teva schizophrenia drug

by Clinical Editor

No Comments

The approval of Teva Pharmaceutical Industries’ original treatment for schizophrenia has been delayed. Teva’s US unit Teva Pharmaceuticals and Me …

Apr 23 2022

Uncategorized

Some Canadians fear mental health groups are reinforcing stigma by erasing ‘schizophrenia’ from their names

by Clinical Editor

No Comments

Some groups supporting people with schizophrenia are erasing the name of the illness from their organization’s name. It’s a controversial decision that they say is being done to combat stigma...